drugset / Trial / NCT00000224
Alternate-Day Buprenorphine. Phase V - 6
CrossoverDouble-blindTreatment
Summary
The purpose of this study is to evaluate buprenorphine blockade challenge.
Timeline
- Start
- 1993-02
- Primary completion
- —
- Completion
- —
Publications
- Background Bickel, Amass, Badger (in preparation) A double-blind controlled trial of buprenorphine dosing every 72 hours in opioid dependenct humans. Bickel, Amass, Badger (in preparation) A double-blind controlled trial of buprenorphine dosing every 72 hours in opioid dependent humans.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |